CinCor Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CinCor Pharma generated cash of -$30,847,206, which is less than the previous year. Cash used in financing activities reached the amount of $141,374,755 last year. Net change in cash is therefore $110,527,549.
Cash Flow
| 2019 | -4.42M | 0 | 15.91M |
|---|---|---|---|
| 2020 | -17.39M | 0 | 31.99M |
| 2021 | -30.84M | 0 | 141.37M |
CINC Cash Flow Statement (2019 – 2021)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
Cash at beginning of period | 26.07M | 11.48M | 0 |
Operating activities | |||
Net income | -50.36M | -22.29M | -5.03M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 0 | 0 | 0 |
Stock-based compensation expense | 2.99M | 15.89K | 3.41K |
| Deferred income tax benefit | 2.99M | 15.89K | 3.41K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 8.42K | -8.42K |
Inventories | 0 | 0 | 0 |
Accounts payable | -3.11M | 2.81M | 952.60K |
Cash generated by operating activities | -30.84M | -17.39M | -4.42M |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 |
Financing activities | |||
Common Stock Issued | 142.86M | 0 | 50K |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 |
Cash used in financing activities | 141.37M | 31.99M | 15.91M |
Net Change In Cash | 110.52M | 14.59M | 11.48M |
Cash at end of period | 136.60M | 26.07M | 11.48M |
| Data source |